This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, ETH Zurich, Institut Pasteur De Lille. Active years: 2018.
Company Filing History:
1 out of 5,383 
1 out of 554 
1 out of 65 
Years Active: 2018
Title: Wolf-Dietrich Hardt: Innovator in Pharmaceutical Treatments
Introduction
Wolf-Dietrich Hardt is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bacterial infections. His innovative approach combines Toll-like receptor (TLR) agonists with antibiotics to enhance treatment efficacy.
Latest Patents
Wolf-Dietrich Hardt holds 1 patent for his invention titled "Methods and pharmaceutical compositions for the treatment of bacterial infections." This patent focuses on the use of TLR agonists in conjunction with antibiotics to treat bacterial infections effectively.
Career Highlights
Throughout his career, Hardt has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Droit et de la Santé de Lille 2. His work in these organizations has contributed to advancements in medical research and pharmaceutical development.
Collaborations
Wolf-Dietrich Hardt has collaborated with notable professionals in his field, including Patrick Kaiser and Jean-Claude Sirard. These collaborations have further enriched his research and innovations.
Conclusion
Wolf-Dietrich Hardt's contributions to pharmaceutical treatments highlight his role as an innovator in the medical field. His work continues to influence the development of effective therapies for bacterial infections.